Stay updated on Belantamab Mafodotin in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Belantamab Mafodotin in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab Mafodotin in Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a new 'Study Status' entry to the record history and updated the latest version indicator to 10. The 2025-12-15 entry was removed from the history.
    Difference
    0.4%
    Check dated 2026-03-26T11:24:41.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision history updated: added version v3.5.0 and removed version v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:59:45.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added revision v3.4.3 to the history and removed revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:29:28.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    The history now shows a new revision entry for v3.4.2 and the government funding operating-status notice was removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-02-11T14:37:03.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    A government funding lapse notice was added to the page, and the revision was updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.8%
    Check dated 2026-02-04T10:36:55.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Glossary toggle is now visible and the diffs are color-coded (green for additions, red for deletions). The page now shows No FEAR Act Data and Revision: v3.4.0 (previously v3.3.4).
    Difference
    1%
    Check dated 2026-01-28T06:25:35.000Z thumbnail image

Stay in the know with updates to Belantamab Mafodotin in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin in Myeloma Clinical Trial page.